Details for Patent: 8,439,864
✉ Email this page to a colleague
Which drugs does patent 8,439,864 protect, and when does it expire?
Patent 8,439,864 protects BYDUREON PEN and is included in one NDA.
Protection for BYDUREON PEN has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has seven patent family members in six countries.
Summary for Patent: 8,439,864
Title: | Device for administering fluid from a multi-chamber ampoule in incremental steps |
Abstract: | An administering device for administering an active substance from a multi-chamber container comprising a first chamber holding a solid active substance and a second chamber holding a dissolving liquid for the active substance, wherein the administering device comprises a mixing device for mixing the active substance with the dissolving liquid and a housing accommodating the mixing device, the container being moveable relative to the housing, and the administering device further comprising a first indicator for indicating a position of the container relative to the housing upon completion of a mixing step, and a second indicator for indicating a position of the container relative to the housing upon completion of a venting step. |
Inventor(s): | Galbraith; Sofia (Solothurn, CH), Moser; Ulrich (Heimiswil, CH), Hirschel; Juerg (Aarau, CH), Thompson; Ian (Burgdorf, CH) |
Assignee: | TecPharma Licensing AG (Burgdorf, CH) |
Application Number: | 12/572,796 |
Patent Claim Types: see list of patent claims | Use; Device; |
Drugs Protected by US Patent 8,439,864
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astrazeneca Ab | BYDUREON PEN | exenatide synthetic | FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS | 022200-002 | Feb 28, 2014 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,439,864
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Germany | 10 2007 016 811 | Apr 5, 2007 |
International Family Members for US Patent 8,439,864
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
China | 101687080 | ⤷ Try a Trial | |||
Germany | 102007016811 | ⤷ Try a Trial | |||
European Patent Office | 2134392 | ⤷ Try a Trial | |||
Japan | 2010523183 | ⤷ Try a Trial | |||
Japan | 5222353 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |